Cessation of gonadotropin-releasing hormone analogue (GnRH-a) upon down-regulation versus conventional long GnRH-a protocol in poor responders undergoing in vitro fertilization

Fertility and Sterility

Volumn 72, Issue 3, 1999, Pages 406-411

  Dirnfeld, Martha ^a   Fruchter, Oren ^a   Yshai, David ^a   Lissak, Arie ^a   Ahdut, Allen ^a   Abramovici, Haim ^a  

^a CARMEL MEDICAL CENTER   (Israel)

Author keywords

GnRH agonist therapy; In vitro fertilization; Ovulation induction; Poor responders

Indexed keywords

FOLLITROPIN; GONADORELIN AGONIST; GONADOTROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HUMAN; MAJOR CLINICAL STUDY; OVULATION INDUCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STIMULATION; TREATMENT OUTCOME; ULTRASOUND;

ADULT; BUSERELIN; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; MALE; OVULATION INDUCTION; PREGNANCY; PROSPECTIVE STUDIES; TRIPTORELIN;

EID: 0033200152     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(99)00289-7     Document Type: Article

References (21)

1. Ben-Rafael Z., Orvieto R., Feldberg D. The poor-responder patient in an in vitro fertilization-embryo transfer (IVF-ET) program. Gynecol Endocrinol. 8:1994;277-286.
2. Scott R.T. Jr. Evaluation and treatment of low responders. Semin Reprod Endocrinol. 14:1996;317-337.
3. Gurgan T., Urman B., Yarali H., Duran H.E. Follicle-stimulating hormone levels on cycle day 3 to predict ovarian response in women undergoing controlled ovarian hyperstimulation for in vitro fertilization using a flare-up protocol. Fertil Steril. 68:1997;483-487.
4. Scott R.T., Navot D. Enhancement of ovarian responsiveness with microdose gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil Steril. 61:1994;880-885.
5. Feldberg D., Farhi J., Ashkenazi J., Dicker D., Shalev J., Ben-Rafael Z. Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels. Fertil Steril. 62:1994;343-346.
6. Olivennes F., Righini C., Fanchin R., Torrisi C., Hazout A., Glissant M., et al. A protocol using a low dose of gonadotrophin-releasing hormone agonist might be the best protocol for patients with high follicle-stimulating hormone concentrations on day 3. Hum Reprod. 11:1996;1169-1172.
7. Surrey E.S., Bower J., Hill D.M., Ramsey J., Surrey M.W. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril. 69:1998;419-424.
8. Padilla S.L., Dugan K., Maruschak V., Shalika S., Smith R.D. Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders. Fertil Steril. 65:1996;796-799.
9. Fujii S., Sagara M., Kudo H., Kagiya A., Sato S., Saito Y. A prospective randomized comparison between long and discontinuous-long protocols of gonadotropin-releasing hormone agonist for in vitro fertilization. Fertil Steril. 67:1997;1166-1168.
10. Faber B.M., Mayer J., Cox B., Jones D., Toner J.P., Oehninger S., et al. Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders. Fertil Steril. 69:1998;826-830.
11. Dirnfeld M., Lejeune B., Camus M., Vekemans M., Leroy F. Growth rate of follicular estrogen secretion in relation to the outcome of in vitro fertilization and embryo replacement. Fertil Steril. 43:1985;379-384.
12. Dozortsev D., De Sutter P., Rybouchkin A., Dhont M. Methodology of intracytoplasmic sperm injection in the human. Assist Reprod Rev. 6:1995;38-44.
13. American Fertility Society. Guidelines for in vitro fertilization, gamete intrafallopian transfer and related procedures. Fertil Steril. 56:1991;194-197.
14. Dirnfeld M., Goldman S., Gonen Y., Koifman M., Calderon I., Abramivici H. A simplified coculture system with luteinized granulosa cells improves embryo quality and implantation rates a controlled study. Fertil Steril. 67:1997;120-122.
15. Dirnfeld M., Gonen Y., Lissak A., Goldman S., Koifman M., Sorokin Y., et al. A randomized prospective study on the effect of short and long buserelin treatment in women with repeated unsuccessful in vitro fertilization (IVF) cycles due to inadequate ovarian response. J In Vitro Fert Embryo Transfer. 8:1991;339-343.
16. Hughes E.G., Fedorkow D.M., Daya S., Sagle M.A., Van de Koppel P., Collins J.A. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer a meta-analysis of randomized controlled trials. Fertil Steril. 58:1992;888-896.
17. Barri PN, Martinez F, Coroleu B, Parera N, Veiga A. Managing nonresponders. In: Fertility and reproductive medicine. Proceedings of the XVI World Congress on Fertility and Sterility, San Francisco, California, 1998:127-37.
18. Smitz J., Van Den Abbeel E., Bollen N., Camus M., Devroey P., Tournaye H., et al. The effect of gonadotropin-releasing hormone (GnRH) agonist in the follicular phase on in-vitro fertilization outcome in normo-ovulatory women. Hum Reprod. 7:1992;1098-1102.
19. Tanbo T., Abyholm T., Bjoro T., Dale P.O. Ovarian stimulation in previous failures from in-vitro fertilization distinction of two groups of poor responders. Hum Reprod. 5:1990;811-815.
20. Karande V.C., Jones G.S., Veeck L.L., Muasher S.J. High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients. Fertil Steril. 53:1990;486-489.
21. Meniru G.I., Craft I.L. Utilization of retrieved oocytes as an index of the efficiency of superovulation strategies for in-vitro fertilization treatment. Hum Reprod. 12:1997;2129-2132.